BioNexus Gene Lab Corp's total assets for Q were $11.16M, a decrease of -2.65% from the previous quarter. BGLC total liabilities were $1.82M for the fiscal quarter, a 2.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.